Budget impact of netupitant/palonosetron for the prevention of chemotherapy-induced nausea and vomiting
Author:
Affiliation:
1. Modeling and Meta-analysis, Pharmerit International, Bethesda, MD, USA;
2. HEOR & Value-Based Medicine, Helsinn Therapeutics (US), Inc, Iselin, NJ, USA
Funder
Helsinn Therapeutics (US), Inc
Publisher
Informa UK Limited
Subject
Health Policy
Link
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2019.1620244
Reference35 articles.
1. Antiemetics: American Society of Clinical Oncology Focused Guideline Update
2. International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): Content and implementation in daily routine practice
3. American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
4. Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting
5. The cost of chemotherapy-induced nausea and vomiting in Italy
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based Chemotherapy;Advances in Therapy;2023-05-28
2. Antiemetic use and chemotherapy induced nausea and vomiting related hospitalization costs after highly or moderately emetogenic chemotherapy;Future Oncology;2023-01
3. Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspective;Supportive Care in Cancer;2022-09-08
4. Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting;Drugs;2021-07
5. Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin;The Oncologist;2020-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3